Philip M. Hansbro

Research interests

Publications

• Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases

  Chemico-Biological Interactions · 2022 · https://doi.org/10.1016/j.cbi.2022.110231

• Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives

  Biomedicine & Pharmacotherapy · 2022 · https://doi.org/10.1016/j.biopha.2022.112951

• Current-status and applications of polysaccharides in drug delivery systems

  Colloids and Interface Science Communications · 2021 · https://doi.org/10.1016/j.colcom.2021.100418

• Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update

  Inflammopharmacology · 2020 · https://doi.org/10.1007/s10787-020-00698-3

• The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress

  Drug Development Research · 2019 · https://doi.org/10.1002/ddr.21571

• Functional effects of the microbiota in chronic respiratory disease

  The Lancet Respiratory Medicine · 2019 · https://doi.org/10.1016/s2213-2600(18)30510-1

• Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

  Chemico-Biological Interactions · 2019 · https://doi.org/10.1016/j.cbi.2019.05.028

• Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals

  Microbiome · 2016 · https://doi.org/10.1186/s40168-016-0181-2

• MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2

  Journal of Allergy and Clinical Immunology · 2016 · https://doi.org/10.1016/j.jaci.2016.04.038

• Pulmonary-intestinal cross-talk in mucosal inflammatory disease

  Mucosal Immunology · 2011 · https://doi.org/10.1038/mi.2011.55

Current projects

No projects listed.